Bashour H, Muhjazi G
Damascus University, Damascus, Syrian Arab Republic.
WHO Country Office, Damascus, Syrian Arab Republic.
East Mediterr Health J. 2016 Jul 10;22(4):267-73. doi: 10.26719/2016.22.4.267.
This paper reviews the epidemiology and determinants of hepatitis B and C in the Syrian Arab Republic as well as their treatment and prevention. A systematic search of Medline, PubMed and Index Medicus for the Eastern Mediterranean Region was carried out in addition to a review of grey literature and relevant datasets in the Syrian Arab Republic. Low to low-intermediate levels of endemicity of both infections were noted at the national level. However, striking geographic differences and high prevalence among high-risk groups were noticeable. As a result of data limitations, further research is needed, and a national control strategy to combat hepatitis B and C in the Syrian Arab Republic should be developed, especially during the current conflict.
本文综述了阿拉伯叙利亚共和国乙型和丙型肝炎的流行病学、决定因素以及治疗和预防情况。除了查阅阿拉伯叙利亚共和国的灰色文献和相关数据集外,还对地中海东部地区的医学期刊数据库、医学文献数据库和医学索引进行了系统检索。在国家层面上,这两种感染的流行程度处于低至中低水平。然而,明显的地理差异以及高危人群中的高患病率是显而易见的。由于数据有限,需要进一步开展研究,并且应制定一项在阿拉伯叙利亚共和国抗击乙型和丙型肝炎的国家控制战略,尤其是在当前冲突期间。